Pharmacokinetics and pharmacodynamics of L-arginine in rats: A model of stimulated neuronal nitric oxide synthesis

Brain Research

Volumn 989, Issue 1, 2003, Pages 67-75

  Heinzen, Erin L ^a   Pollack, Gary M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CB#7360 Kerr Hall ^*  (United States)

Author keywords

Circadian variation; L Arginine; Microdialysis; Nitric oxide; Pharmacokinetic pharmacodynamic modeling; Rat

Indexed keywords

ARGININE; NITRIC OXIDE; SODIUM CHLORIDE;

AMPEROMETRY; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG UPTAKE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; MODEL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT;

EID: 0142102448     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03370-5     Document Type: Article

References (35)

1. Ayers N.A., Levente K., Krueger J.M. Circadian variation of nitric oxide synthase activity and cytosolic protein levels in brain. Brain Res. 707:1996;127-130.
2. Babey A.M., Kolesnikov Y., Cheng J., Inturrisi C.E., Trifilletti R.R., Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology. 33:1994;1463-1470.
3. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. J. Parenter. Enteral. Nutr. 10:1986;227-238.
4. Ben-Eliyahu S., Marek P., Vaccarino A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
5. Bhargava H.N., Bain J.T. Effects of acute administration of L-arginine on morphine antinociception and morphine distribution in central and peripheral tissues of mice. Pharmacol. Biochem. Behav. 61:1998;29-33.
6. Bhargava H.N., Cao Y.J., Zhao G.M. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice. Peptides. 18:1997;797-800.
7. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain. 68:1996;229-237.
8. Bush M.A., Pollack G.M. Pharmacokinetics and pharmacodynamics of 7-nitroindazole, a selective nitric oxide synthase inhibitor, in rat hippocampus. Pharm. Res. 18:2001;1607-1612.
9. Cockrell A.S., Gray L., Van der Heyde H., Hoffman J.M., Laroux J.M., Lefer D.J., Kawachi S., Scalia R. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid. Redox Signal. 2:2000;391-396.
10. Dambisya Y.M., Lee T.L. A thromboelastography study on the in vitro effects of L-arginine and L-NG-nitro arginine methyl ester on human whole blood coagulation and fibrinolysis. Blood Coagul. Fibrinolysis. 7:1996;678-683.
11. Dhanakoti S.N., Brosnan J.T., Brosnan M.E., Herzberg G.R. Net renal arginine flux in rats is not affected by dietary arginine or dietary protein intake. J. Nutr. 122:1992;1127-1134.
12. Dunbar S.A., Yaksh T.L. Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat. J. Pharmacol. Exp. Ther. 281:1997;1219-1225.
13. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., Inturrisi C.E. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. 56:1994;69-75.
14. Elsner J.B., Tsonis A.A. Singular Spectrum Analysis. 1996;Plenum Press, New York.
15. Feelisch J.B., Stamler J.S. Methods in Nitric Oxide Research. 1996;147-160 Wiley, Chichester.
16. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 349:1997;837-842.
17. Gulbenkians S., Uddman R., Edvinsson L. Neuronal messengers in human cerebral circulation. Peptides. 22:2001;995-1007.
18. E.L. Heinzen, G.M. Pollack, Use of an electrochemical nitric oxide sensor to detect neuronal nitric oxide production in conscious, unrestrained rats, J. Pharmacol. Toxicol. Methods, in press.
19. Kapas L., Shibata M., Kimura M., Kreuger J.M. Inhibition of nitric oxide synthase suppresses sleep in rabbits. Am. J. Physiol. 266:1994.
20. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. USA. 90:1993;5162-5166.
21. Kubes P., Suzuki M., Granger D.N. NO: an endogenous modulator of leukocyte adhesions. Proc. Natl. Acad. Sci. 88:1991;4651-4655.
22. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between NO and dementia of the Alzheimer's type. Brain Res. Rev. 35:2001;73-96.
23. Mahar Doan K., Lakhman S., Boje K. Blood-brain barrier transport studies of organic guanidine cations using an in situ brain perfusion technique. Brain Res. 876:2000;141-147.
24. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189-192.
25. Marek P., Ben-Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
26. Marek P., Ben-Eliyahu S., Vaccarino A.L., Liebeskind J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
27. Milner J.A., Wakeling A.E., Visek W.J. Effect of arginine deficiency on growth and intermediary metabolism in rats. J. Nutr. 104:1974;1681-1689.
28. Moncada S., Higgs E.A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
29. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
30. Rauhala P., Idanpaan-Heikkila J.J., Tuominen R.K., Mannisto P.T. N-Nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol. 259:1994;57-64.
31. Siaghy E.M., Devaux Y., Schroeder H., Sfaksi N., Ungureanu-Longrois D., Zannad F., Villemot J.P., Nabet P., Mertes P.M. High-performance liquid chromatographic analysis of muscular interstitial arginine and norepinephrine kinetics. A microdialysis study in rats. J. Chromatogr. B Biomed. Appl. 745:2000;279-286.
32. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
33. Tunctan B., Weigl Y., Dotan A., Peleg L., Zengil H., Ashkenazi I., Abacioglu N. Circadian variation of nitric oxide synthase activity. Chrono Biol. Int. 19:2002;393-404.
34. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog. Neurobiol. 64:2001;365-391.
35. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1998;1-17.